Skip to main content
The Journal of Liquid Biopsy logoLink to The Journal of Liquid Biopsy
. 2026 May 7;12:100472. doi: 10.1016/j.jlb.2026.100472

Erratum to “The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing” [J. Liq. Biopsy 12 (2026) 100461]

Benjamin A Bleiberg a,b,⁎, Dylan G Scholes a, Lauren Reed-Guy a,b, Devaki Dravid a, Lova L Sun a,b,c, Aditi P Singh a,b, Roger B Cohen a,b, Corey J Langer a,b, Melina E Marmarelis a,b,c, Charu Aggarwal a,b,c
PMCID: PMC13309971  PMID: 42369530

The publisher regrets that the declaration of competing interest statement was omitted from the published version of this article. The statement should read as follows: "The authors declare no competing interests relevant to this work."

The publisher would like to apologise for any inconvenience caused.


Articles from The Journal of Liquid Biopsy are provided here courtesy of Elsevier

RESOURCES